Neomedic International

What Neomedic International does

Neomedic International is a privately held Spanish medical device company, headquartered in Terrassa, Spain, focused on developing minimally invasive surgical solutions for pelvic floor disorders. The company designs, manufactures, and distributes a portfolio of eight medical device systems organized across three therapeutic areas: female urinary incontinence (Needleless, KIM System, Remeex Female), male urinary incontinence (Remeex Male), and pelvic organ prolapse (Anchorsure, Surelift, MIPS, Uplift). Its technology centers on adjustable mesh and fixation systems, including the Remeex platform (the only mesh allowing lifetime urethral support adjustment with more than 15 years of clinical follow-up), the Needleless single-incision transobturator tape mesh (the first single-incision mesh with completed FDA 522 post-market surveillance studies), and a Dynamic Pressure Transmission System that mimics natural abdominal pressure mechanics.

The company generates revenue primarily through hardware sales of medical devices to healthcare professionals and medical institutions. Its go-to-market combines direct enterprise sales to hospitals and specialty clinics with a global distributor network covering more than 40 countries (the About page indicates more than 45). The company maintains a multilingual website (English, Spanish) and a Moodle-based e-learning platform (elearning.neomedic.com) offering surgeon training in English, Spanish, German, and Italian. Pricing is quote-based with no public disclosure. The company targets gynecologists, urologists, urogynecologists, and reconstructive surgeons at institutions including Cleveland Clinic, University of Alabama at Birmingham, and Fundación Puigvert.

Founded around 1999 (the company celebrates 25 years) and operating with 11-50 employees, Neomedic has no disclosed parent company, institutional investors, funding rounds, or revenue figures. Product differentiation rests on proprietary mesh design, post-operative adjustability, and accumulated clinical follow-up data rather than on software, imaging, or AI components. The operating model is fundamentally hardware-centric and channel-mediated, with surgeon training and key-opinion-leader engagement serving as the principal demand-generation levers.

Name

Neomedic International

Legal name

Neomedic International

Website

https://neomedic.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Neomedic International is a Spanish medical device company developing minimally invasive surgical solutions for pelvic floor disorders, including urinary incontinence and prolapse. It distributes eight branded systems through a global partner network in 40+ countries, serving urologists, gynecologists, and reconstructive surgeons.

Ownership category

akta.pro rank

Product category

Pelvic Floor Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

akta.pro secondary industries

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Female Pelvic Medicine & Reconstructive Surgery (Urogynecology) (HLAKAOAC), Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF), Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF)

Keywords

• Pelvic floor devices
• Urinary incontinence treatment
• Pelvic prolapse surgery
• Surgical mesh systems
• Minimally invasive gynecology

Headquarters

HQ city

Terrassa

HQ country

Spain

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Neomedic International generates revenue through the sale of medical devices including surgical meshes, slings, and fixation systems for pelvic floor surgery. The company sells directly to healthcare professionals and through a global distribution network spanning more than 40 countries.
2. Professional Training and Education: The company operates an e-learning platform (elearning.neomedic.com) powered by Moodle, providing training content for healthcare professionals on the use of their products and surgical techniques.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Neomedic International develops, manufactures, and distributes minimally invasive surgical devices for pelvic floor disorders, including adjustable mesh systems, slings, and fixation devices used to treat urinary incontinence (male and female) and pelvic organ prolapse. The portfolio comprises eight distinct medical device systems distributed to more than 40 countries through a global network of distributors and direct sales to healthcare institutions.

Product overview

Neomedic International is a medical device company founded over 25 years ago that develops and distributes surgical solutions for pelvic floor disorders, specifically urinary incontinence (male and female) and pelvic organ prolapse. The product portfolio consists of eight distinct medical device systems organized into three therapeutic categories: Female Incontinence (Needleless, KIM System, Remeex Female), Male Incontinence (Remeex Male), and Prolapse (Anchorsure, Surelift, MIPS, Uplift). All products are minimally invasive surgical devices designed to improve physician surgical outcomes and patient quality of life. The company distributes to more than 45 countries through a global distributor network.

Differentiator

Problem solved

Functional benefit

Brands

• Remeex Female: Long-term readjustable mesh system for treatment of female stress urinary incontinence with Dynamic Pressure Transmission System
• Remeex Male
• Needleless
• KIM System
• Anchorsure
• Surelift
• MIPS
• Uplift

Products and services

• Needleless Single-incision TOT (transobturator tape) mesh for female stress urinary incontinence that requires no skin incisions, anchors, or needles, using a pocket positioning system for biological fixation to the internal obturator muscle. The first single-incision mesh with completed FDA 522 post-market surveillance studies.
• KIM System (Knotless Incontinence Mesh) Tension-free, 100% macroporous, macrorigid and microelastic knotless mesh for treatment of mild to moderate female stress urinary incontinence via TOT and TVT approaches. The knotless design reduces micropores, roughness, and material volume compared to traditional meshes.
• Remeex Female Long-term readjustable mesh system for female stress urinary incontinence featuring the Dynamic Pressure Transmission System. The only mesh that allows urethral support adjustment at any time throughout a patient's life, with over 15 years of clinical follow-up. Indicated for non-hypermobile urethra, Intrinsic Sphincter Deficiency, and failed traditional sling procedures.
• Remeex Male Long-term adjustable and readjustable mini-sling for male stress urinary incontinence, often post-prostatectomy. The Dynamic Pressure Transmission System enables post-operative adjustment 24-48 hours after surgery, with re-adjustment possible at any time if incontinence recurs.
• Anchorsure Minimally invasive fixation system for transvaginal sacrospinous ligament fixation in pelvic floor reconstructive surgery for vaginal prolapse treatment. Narrow and straight design enables fixation without complex traditional sutures, facilitating precise placement with minimal dissection.
• Surelift Adjustable prolapse mesh with 6 fixation points (two anchors to the sacrospinous ligament plus four additional arms through the obturator muscle). Universal mesh for anterior, vaginal vault, and posterior prolapse, designed to prevent mesh displacement during implant retraction and maintain tension-free positioning.
• MIPS (Minimally Invasive Prolapse System) Minimally Invasive Prolapse System for repair of pelvic organ prolapse through a single transvaginal incision. Mesh is fixed to the sacrospinous ligament using anchors and to the internal obturator muscle via two adjustable arms with a pocket system, leaving the mesh tension-free and wrinkle-free.
• Uplift Minimally invasive single-incision system designed for sacrocolpopexy via abdominal approach (open, laparoscopic, or robotic surgery). Uses blunt-tip anchors for sacral promontory fixation. Indicated for anterior, mid-anterior, or posterior prolapse and can be used without prior hysterectomy. Includes Independent Compartment Tension System for differentiated tension adjustment per compartment.

Quantifiable outcome

• Remeex Female has more than 15 years of clinical follow-up demonstrating long-term continence outcomes
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Others

• Karl Storz: Leading endoscopy and minimally invasive surgical equipment vendor. Not a direct mesh competitor, but adjacent through the laparoscopic/robotic pelvic surgery ecosystem in which Neomedic's Uplift system is designed to be used.
• Intuitive Surgical: Dominant surgical robotics platform whose da Vinci systems are used in sacrocolpopexy and other pelvic floor procedures. Adjacent rather than direct competitor, but influences the procedural environment in which Neomedic's Uplift and similar devices are implanted.

Direct peers

• Cook Medical: Active in urology and pelvic floor reconstruction with surgical mesh and fixation devices. Overlaps with Neomedic in minimally invasive sling and prolapse repair solutions.
• Coloplast: Direct competitor in pelvic floor and incontinence surgery, with sling products (e.g., Altis) and a dedicated surgical urology business closely aligned with Neomedic's portfolio.
• Caldera Medical: Specialist medical device company focused exclusively on pelvic floor disorders (incontinence and prolapse), with a portfolio of mesh and biological products. Closest niche specialist peer to Neomedic.
• Promedon: Specializes in urology, urogynecology, and pelvic floor implants (e.g., Nazca, Ophira). Comparable product set targeting the same surgeon base, with overlapping indications in sling and prolapse.

Broad incumbents

• B. Braun: Diversified medical device manufacturer with an active urology and surgical meshes business, competing in pelvic floor reconstruction and incontinence products.
• Ethicon (Johnson & Johnson): Long-established player in pelvic floor mesh (Gynecare TVT family) and broader surgical devices. Subject to significant historical mesh litigation, but remains a benchmark competitor and a category-defining incumbent.
• Boston Scientific: Major medtech incumbent with a significant pelvic floor mesh portfolio (Obtryx, Advantage, Lynx). Competes head-to-head with Neomedic in sling and prolapse markets but operates across many other franchises.
• Endo International (Astora / AMS): Owns or has owned the American Medical Systems pelvic floor mesh franchise (Elevate, Apogee, Perigee). Competed directly in the same product category and provides a benchmark for category-level economics and litigation exposure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/NeomedicInt
• Facebookfacebook.com/Neomedic-International-1525567124211518
• LinkedInlinkedin.com/company/neomedic-international

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neomedic International